Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA

Share this content:
Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA
Metformin, Sitagliptin Prolong Normoglycemia Remission in DKA

FRIDAY, Sept. 2, 2016 (HealthDay News) -- For patients with new-onset diabetic ketoacidosis (DKA) and severe hyperglycemia, metformin and sitagliptin treatment after normoglycemia remission correlate with increased relapse-free survival and prolonged remission, according to a study published online Aug. 29 in Diabetes Care.

Priyathama Vellanki, M.D., from the Emory University School of Medicine in Atlanta, and colleagues conducted a prospective four-year study involving 48 African-American subjects with DKA and severe hyperglycemia. Participants were randomized to metformin (17 participants), sitagliptin (16 participants), or placebo (15 participants) after normoglycemia remission. Oral glucose tolerance tests were conducted at randomization, at three months, and every six months for a median of 331 days.

The researchers found that the metformin and sitagliptin groups had significantly higher relapse-free survival compared with placebo (P = 0.015), and significantly prolonged mean time to relapse (480 versus 305 days; P = 0.004). Compared with placebo, the probability of relapse was significantly lower for metformin and sitagliptin (hazard ratios, 0.28 and 0.31, respectively). Compared with those with hyperglycemia relapse, individuals who remained in remission had a higher disposition index and incremental area under the curve for insulin, with no significant changes in insulin sensitivity.

"This study shows that near-normoglycemia remission was similarly prolonged by treatment with sitagliptin and metformin," the authors write. "The prolongation of remission was due to improvement in β-cell function."

Several authors disclosed financial ties to pharmaceutical companies, including Merck, which manufactures sitagliptin.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Montelukast Associated With Nightmares, Depression

Montelukast Associated With Nightmares, Depression

Odds of depression, aggressive behavior, suicide ideation, nightmares, headaches all increased

Alcohol Aids Cerebellar Deficit From Movement Disorder

Alcohol Aids Cerebellar Deficit From Movement Disorder

Cerebellar networks may play key role in symptom generation in these patients

Oral Beats Topical Isotretinoin for Treatment of Warts

Oral Beats Topical Isotretinoin for Treatment of Warts

Oral treatment shows better, earlier response than topical isotretinoin

is free, fast, and customized just for you!

Already a member?

Sign In Now »